These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8976833)

  • 21. Interventions for the prevention of mycobacterium avium complex in adults and children with HIV.
    Uthman MM; Uthman OA; Yahaya I
    Cochrane Database Syst Rev; 2013 Apr; (4):CD007191. PubMed ID: 23633339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of rifabutin resistance with prophylaxis for disseminated Mycobacterium avium complex.
    Böttger EC; Wallace RJ
    Lancet; 1994 Nov; 344(8935):1506-7. PubMed ID: 7734014
    [No Abstract]   [Full Text] [Related]  

  • 23. How to treat bacteraemic Mycobacterium avium complex disease.
    Chin DP; Hopewell PC
    Lancet; 1995 Oct; 346(8980):920-1. PubMed ID: 7564723
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical experience with rifabutin in the treatment of mycobacterial infections.
    De Cian W; Sassella D; Wynne BA
    Scand J Infect Dis Suppl; 1995; 98():22-6. PubMed ID: 8867175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment review. Rifabutin.
    Co M
    J Assoc Nurses AIDS Care; 1994; 5(1):45-50. PubMed ID: 8167311
    [No Abstract]   [Full Text] [Related]  

  • 26. Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection.
    Fichtenbaum CJ; Zackin R; Feinberg J; Benson C; Griffiths JK;
    AIDS; 2000 Dec; 14(18):2889-93. PubMed ID: 11153670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention and treatment of Mycobacterium avium complex infection.
    Mangura BT; Reichman LB
    Res Microbiol; 1994; 145(3):181-7. PubMed ID: 7809470
    [No Abstract]   [Full Text] [Related]  

  • 28. Azithromycin in the prophylaxis of opportunistic infections in AIDS.
    McCutchan JA
    Int J STD AIDS; 1996; 7 Suppl 1():34-7. PubMed ID: 8652726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corneal endothelial deposits associated with rifabutin use.
    Coutinho AB; Cheema D; Pereira PR; Souza Filho JP; Burnier MN
    J Ocul Pharmacol Ther; 2005 Apr; 21(2):166-9. PubMed ID: 15857283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rifabutin prophylaxis against Mycobacterium avium complex infections in HIV-infected patients: impact on the incidence of campylobacteriosis.
    Pulik M; Genet P; Leturdu F; Lionnet F; Louvel D; Touahri T
    AIDS Patient Care STDS; 1999 Aug; 13(8):467-72. PubMed ID: 10800525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing Mycobacterium avium complex in patients who are using protease inhibitors: a cost-effectiveness analysis.
    Bayoumi AM; Redelmeier DA
    AIDS; 1998 Aug; 12(12):1503-12. PubMed ID: 9727572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycobacterium avium complex infection, rifabutin, and uveitis--is there a connection?
    Nichols CW
    Clin Infect Dis; 1996 Apr; 22 Suppl 1():S43-7; discussion S47-9. PubMed ID: 8785256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex.
    Masur H
    N Engl J Med; 1993 Sep; 329(12):898-904. PubMed ID: 8395019
    [No Abstract]   [Full Text] [Related]  

  • 34. Panuveitis associated with rifabutin prophylaxis in a pediatric HIV-positive patient.
    Johnson TM; Desroches G
    J Pediatr Ophthalmol Strabismus; 1998; 35(2):119-21. PubMed ID: 9559514
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluating the quality of life associated with rifabutin prophylaxis for Mycobacterium avium complex in persons with AIDS: combining Q-TWiST and multiattribute utility techniques.
    Revicki DA; Simpson KN; Wu AW; LaVallee RL
    Qual Life Res; 1995 Aug; 4(4):309-18. PubMed ID: 7550179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uveitis associated with rifabutin prophylaxis.
    Havlir D; Torriani F; Dubé M
    Ann Intern Med; 1994 Oct; 121(7):510-2. PubMed ID: 8067648
    [No Abstract]   [Full Text] [Related]  

  • 37. Rifabutin prophylaxis against Mycobacterium avium complex infection.
    Goldschmidt RH; Hearst N; Chambers DB
    N Engl J Med; 1994 Feb; 330(6):436-7; author reply 438. PubMed ID: 7904328
    [No Abstract]   [Full Text] [Related]  

  • 38. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
    Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
    J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rifabutin prophylaxis against Mycobacterium avium complex infection.
    Zbrozek AS
    N Engl J Med; 1994 Feb; 330(6):437; author reply 438. PubMed ID: 7904329
    [No Abstract]   [Full Text] [Related]  

  • 40. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex for adults and adolescents infected with human immunodeficiency virus. U.S. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex.
    MMWR Recomm Rep; 1993 Jun; 42(RR-9):14-20. PubMed ID: 8393134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.